1H magnetic resonance spectroscopy (MRS) yields site-specific signatures that directly report metabolic concentrations, biochemistry and kinetics—provided spectral sensitivity and quality are sufficient. Here, an enabling relaxation-enhanced (RE) MRS approach is demonstrated that by combining highly selective spectral excitations with operation at very high magnetic fields, delivers spectra exhibiting signal-to-noise ratios >50:1 in under 6 s for ~5 × 5 × 5 (mm)3 voxels, with flat baselines and no interference from water. With this spectral quality, MRS was used to interrogate a number of metabolic properties in stroked rat models. Metabolic confinements imposed by randomly oriented micro-architectures were detected and found to change upon ischaemia; intensities of downfield resonances were found to be selectively altered in stroked hemispheres; and longitudinal relaxation time of lactic acid was found to increase by over 50% its control value as early as 3-h post ischaemia, paralleling the onset of cytotoxic oedema. These results demonstrate potential of 1H MRS at ultrahigh fields.
Magnetic resonance imaging (MRI) is indispensable for understanding the biology of healthy tissues1,2 as well as for non-invasively diagnosing disease3,4. MRI delivers valuable spatially resolved insight despite its primary focus on a single molecule: the water residing within tissues. Central to this achievement are the diverse physical interactions that will affect the magnetic resonance (MR) signal of water; foremost among them are the contrast mechanisms that, based on morphology, function and disease, modulate spin–lattice and spin–spin (T1 and T2) relaxation times, as well as its diffusivity and hydrogen exchanges5,6. Despite this valuable and varied source of contrast mechanisms many of the properties reflected by water remain ambiguous, challenging the biological interpretation of these changing MR parameters. In stroke, for example, increases in diffusion-weighted MRI signals of water are clear reporters on the early onset of an infarct7, yet the structural changes underlying these signal changes remain the subject of vigorous investigations8,9. Clearly, a much richer information about physiology, microstructure and function, would arise if MR measurements were to shift from ‘the solvent’ to the numerous small molecules that are actually involved in the biological functions. For central nervous system (CNS) studies, in particular, endogenous metabolites could report on crucial events such as neurotransmission, pH, redox states, membrane synthesis and energetic turnover10,11. Metabolites could also serve as early reporters for neurological disorders such as dementia, schizophrenia, and Parkinson’s and Huntington’s diseases12, about the fate of malignancies13, and about ischaemic processes7. Magnetic resonance spectroscopy (MRS) is an ideal methodology to investigate these CNS metabolic aspects in vivo and noninvasively14. Whereas MRI contrasts delineate anatomical landmarks based on single resonance of water, MRS seeks to resolve the frequency signatures associated with various endogenous metabolites via their chemical shifts14,15. MRS thus can report about neurotransmitters (glutamate, aspartate and γ-aminobutyric acid), bioenergetic metabolites (creatines (Cre), lactic acid (Lac)) and osmolytes (N-acetyl-asparate (NAA)), molecules involved with membrane synthesis (cholines (Cho)), sugars (glucose, inositols) and other CNS metabolites present at millimolar concentrations14,15. MRS has afforded valuable insights into the nature of disease metabolism16,17,18; furthermore, since some of these metabolites are selectively compartmentalized, for example, NAA is considered intraneuronal, whereas myo-inositols reside mostly in astrocytes, MRS can potentially resolve structurally distinct cellular environs.
Despite all this potential, most MRS measurements are limited to depicting in vivo relative concentrations of various metabolites. This is particularly restrictive when considering the wealth of information that water-based MRI successfully delivers by exploiting relaxation, diffusion and other contrast mechanisms. Indeed, complementing information about metabolic concentrations —or even metabolic density maps—with 1H MR’s many other potential sources of contrast could provide a much richer information about a tissue under investigation. The current restricted versatility of MRS does not reflect an intrinsic limitation but is rather a consequence of (i) the need to suppress the ~10,000 times stronger water resonance to enable the observation of millimolar-level metabolites, a process that often creates spectral distortions hindering complex MRS measurements; and (ii) the limited sensitivity associated with the observation of low-concentration endogenous metabolites that a priori precludes rapid experiments and, hence, the execution of more complex and time-consuming MRS sequences. These two factors conspire to render the relaxation- and diffusion-based probing of metabolites under in vivo conditions19,20,21,22,23,24 a considerable challenge.
In this study, we present and demonstrate a general MRS approach that enables high-fidelity measurements of relaxation, diffusion and kinetic interactions of metabolites within healthy and diseased tissues. The method yields 1H MRS with high signal-to-noise ratio (SNR) per unit time by harnessing two complementary features: the use of a non-water-suppressed sequence25 that benefits from an enhanced relaxation arising from selective frequency excitation26, and the execution of these experiments at ultrahigh magnetic fields for which 1H MRS is greatly facilitated by polarization, spectral and—foremost—relaxation characteristics. Sensitized in this fashion, the duration of localized in vivo MRS measurements can be remarkably reduced, enabling the observation of novel, metabolite-specific behaviours based on restricted diffusion, relaxation and exchange. This potential is demonstrated with an array of ‘firsts’ in CNS spectroscopy in animal models of unilateral stroke, including SNRs exceeding 50:1 from 6-s in vivo recordings, the observation of differential metabolic diffusive confinements in disordered anisotropic tissue microstructures and new metabolic fingerprints of stroke arising from spectral regions located downfield of the water resonance. Finally, relaxation-based 1H MRS measurements were used to probe differential interactions of various metabolites upon stroke, suggesting changing microscopic environments and macromolecular bindings. Overall, this strategy facilitates the study of relationships between the microstructure of the brain, metabolism and interactions of endogenous metabolites with their host tissues. Numerous extensions of this potential to other CNS diseases and to other biological tissues, can be envisioned.
Features of ultrahigh-field relaxation-enhanced 1H MRS
The relaxation-enhanced (RE) MRS methodology hereby employed, relies on an excitation-contrast-localization-acquisition layout (Fig. 1). While numerous variants of this scheme can be conceived, a key common element is the avoidance of long-term perturbations of water or macromolecular resonances based on a RE strategy25. In RE MRS, the data are collected using a highly spectrally selective spin echo sequence targeting only the resonances of interest; for instance, the methyl peaks of Lac, NAA, Cre and Cho. In the absence of pre-saturation or crushing, this selectivity ensures that the bulk of both the water and macromolecular reservoirs remain largely unperturbed, benefiting the excited spins by minimizing potential magnetization transfer processes driven by cross-relaxation from surrounding protons, and/or facilitating a fast recovery driven by chemical exchanges between labile 1Hs and water26. Selectively excited metabolic resonances can then be subjected to a variety of contrast mechanisms that sensitize them to their environments. In this study filters were applied that monitored the responses of metabolites to restricted diffusion and tissue micro-architectures, that used spectral profiles tailored to directly observe the labile protons resonating downfield of water, and that incorporated various relaxation-monitoring delays to measure the dynamic properties of metabolites. For all filters, the chemical shift evolution accrued during the initial excitation is refocused with frequency-selective pulses so as to ensure high-quality 1H lineshapes. With these selective contrasts imposed, the targeted metabolites are spatially localized using a fully refocused module confining the observable magnetization to a volume of interest, and signals are finally acquired with a spectroscopic or spectroscopic imaging module (Fig. 1).
This strategy leads to spatially localized spectra, reflecting the contrasts imposed with a very high sensitivity (Fig. 2). In vivo1H MRS acquired in only 6 s (eight scans) from a 5 × 5 × 5 (mm)3 rat brain voxel at 21.1 T (900 MHz 1H frequency) showed a SNR >50:1 for the NAA peak (with a SNR >10:1 and a clean baseline observed in only one scan), and a nearly complete absence of the water resonance without any form of active suppression (Fig. 2a). Besides the natural increase in sensitivity afforded by a 21.1 T magnet, inherent factors contributing to the high SNR and high signal-to-artefact ratios observed for these MR spectra pertain to the relaxation times arising at these ultrahigh fields. At 21.1 T, T2 relaxation times are nearly an order of magnitude longer for the metabolites than for their water 1H counterparts, while metabolic T1 times are ~2–3 times shorter than those of water. These favourable parameters, along with the power dependence of SNR on B0, are exploited by the RE strategy to obtain the clean metabolic spectra and flat MRS baselines shown in Fig. 2a. Figure 2b displays RE 1H MRS spectra recorded in 5 min from identical voxels centred in the ipsi- and contralateral hemispheres of a stroked rat, 24-h post ischaemia. The expected increase in Lac and decrease in NAA resonance intensities are readily observed, with the SNR for NAA in the contralateral hemisphere approaching 300. Notice as well that despite its J-coupling, Lac’s methyl resonance appears well phased; this stems from the high spectral selectivity of the sequence which, by not inverting Lac’s methyl coupling partner, performs a sort of homonuclear J-echo. With this good sensitivity and spectral fidelity as a starting point, more elaborate MRS schemes can be conducted as illustrated below.
Metabolic confinements monitored in vivo upon ischaemia
Diffusion-weighted MRI has a central role in the early diagnosis and prognosis of stroke7,27,28, yet the determinants underlying diffusivity variations of water post ischaemia are still not fully understood9,29. The nonspecific nature of water-based MRI measurements prevents the selective probing of distinct cellular morphologies. By contrast, metabolites can exhibit a selective compartamentalization30, and extending diffusion measurements to metabolic resonances could crucially improve the specificity of the measurements towards different neural tissue elements18,20,31,32,33,34,35. One of the goals of this study was to explore the potential of in vivo RE MRS to detect the underlying micro-architectures to which selected metabolites are confined in healthy and stroked hemispheres. To this end, we focused on angular double-pulsed field gradient (dPFG) experiments36 (shaded box under ‘Filter’ in Fig. 1)—a challenging measurement that within the context of CNS studies has so far been performed only on the abundant water signals. dPFG correlates random molecular displacements by applying pairs of diffusion-sensitizing gradients G1 and G2 whose relative angle ψ is varied. When restricted diffusion occurs, this kind of correlation can probe local restrictions via characteristic signal amplitude modulations36,37,38, whose angular dependency can be used to extract microarchitectural features even in highly heterogeneous scenarios—for instance, when compartments are randomly oriented38. To study the kind of restricted diffusion that metabolites may experience in randomly oriented brain microstructures in health and in disease, dPFG RE 1H MRS experiments were conducted in rats that had been subject to a transient, 1.5-h middle cerebral artery occlusion (MCAO) to produce a severe unilateral ischaemia (Fig. 3, upper inset). dPFG 1H MRS spectra arising from signals localized on the contra- and ipsilateral MCAO hemispheres were recorded 24-h post ischaemia, by varying the angle ψ between G1 and G2. Despite the complexity and signal losses associated with the angular dPFG experiment, whose successful in vivo execution even on the strong water signals upon stroke is yet to be achieved, high-fidelity data from the metabolites of interest were obtained (Fig. 3a,b). Notice the negligible residual water signal, the absence of baseline distortions and the short acquisition times (~4 min) that characterize these spectra—for which the SNR of NAA in the contralateral hemisphere reached ~250 for ψ=0°. The cos(2ψ)-like modulations arising from these data (Fig. 3c,d) reflect the diffusion mode of these metabolites, representing the first unequivocal evidence for restricted metabolic diffusion in the randomly oriented compartments of an in vivo brain. The local anisotropies of the otherwise randomly oriented structures leading to these oscillations can be described by apparent L/R eccentricity ratios, where L is a cylinder’s long axis and R is its radius.37 Fits of these data under the assumption of fully restricted diffusion, reveal that Lac, NAA, Cre and Cho eccentricities in the contralateral hemisphere are 9.7±2.0, 11.2±0.9, 10.6±0.9 and 11.1±0.8, whereas in the ipsilateral hemisphere these increase to 11.9±0.9, 12.7±0.8, 12.5±0.6 and 12.1±0.9, respectively. When similar spectra were quantified across rats, a statistically significant increase in eccentricity was observed 24 h after the onset of ischaemia for NAA, Cre and Cho (P<0.05, N=6, one-way analysis of variance, Fisher means comparison); interestingly, this statistical analysis finds Lac diffusing in consistently less eccentric spaces compared with NAA (P<0.05, one-way analysis of variance, Fisher means comparison), which is considered an intraneuronal marker. Because the dPFG amplitude modulations reflect local eccentricities, this difference highlights a genuine confinement of Lac to more spherical environments, presumably reflecting a preferential accumulation of Lac in intracellular—environments. It should be noted that the long echo time (TE) of the sequence inherently weights dPFG experiments towards long T2 species; however, as metabolic T2s are in any case naturally longer than their water counterparts, this provides ample time for diffusing metabolites to probe the morphology in which they are confined. Findings such as these highlight the potential specificity enhancement entailed by probing metabolites that are often confined to specific tissues or cells (such as NAA in neurons and myo-inositol in astrocytes) rather than global water signals.
Downfield 1H resonances as potential stroke biomarkers
Nearly all metabolic MRS studies performed in vivo within the context of CNS disorders have hitherto focused on the spectral region upfield of water where aliphatic protons resonate14,15. The spectral region positioned downfield of water (5–10 p.p.m.) has been probed only rarely in healthy tissues39,40 or in the context of disease41, most likely because this region contains labile protons whose exchange with water renders them hard to detect upon using conventional, active solvent suppression. This downfield spectral region contains important resonances including ATP, glutamine, glutamate, gluthatione, homocarnosine, imidazole, NAD+, phenylalanine, phosphocreatine, tryptophane and tyrosine42, whose direct characterization could open new vistas in understanding CNS metabolism. To test whether the approach in Fig. 1 is suitable for downfield evaluations, in vivo experiments were performed with an excitation involving a single band targeting the 5.7–9.7 p.p.m. region and exhibiting a ≤0.06° pulse angle excitation at the 4.75-p.p.m. water frequency. Spectra resulting from ipsi- and contralateral hemispheres of a stroked rat 24-h post ischaemia collected in only 10 min reveal at least nine resolved resonances (Fig. 4). Out of these, NAA can be unambiguously assigned, yet the origin of the other peaks remains to be fully identified39,40,42. The potential of these peaks as stroke biomarkers is also evident in Fig. 4: peaks labelled ‘a’, ‘c’ and ‘h’ are either unaffected by the ischaemic process or promptly recover from it, whereas all remaining peaks show varying decreases in their amplitudes. Assuming that the assignments provided in vitro43 apply also in vivo, peaks ‘a’ and ‘c’ could potentially represent hydroxyl moieties of glucose or glucose-6-phosphate, which would imply that, by 24-h post ischaemia, glucose levels are restored in brain tissue by reperfusion. Also, assuming that the peak at ~8.3 p.p.m. reflects the adenosine moiety ATP (one of the few abundant metabolites resonating at such high p.p.m. values42), the decrease shown by ‘i’ in Fig. 4 suggests a significant impairment of the energetic cycle. It is overall clear that, pending their full assignment, the differential behaviours observed for the numerous peaks now resolved in the downfield region can provide valuable insight to diagnose and evaluate stroke.
Metabolic interactions with endogenous macromolecules
Additional valuable targets for metabolic characterizations rest in the spin relaxation times, which could be diagnostic reporters on the binding of metabolites to larger macromolecular structures or probes of compartmentalization. Although considerable efforts have been invested in assessing these relaxation times19,21,22, including in the context of CNS disease44, these measurements are still challenged by the need to optimize water suppression and by limited sensitivity. Here, we utilized the RE MRS approach to measure the post-stroke T1s of Lac, Cho, Cre and NAA in vivo upon applying a progressive saturation filter21. Figure 5a,b shows data collected 3-h post ischaemia from the contra- and ipsilateral hemispheres of a representative animal, respectively. The expected exponential buildup of metabolic signals with increasing repetition time (TR) is readily observed for all resonances of interest, with a high SNR that yields the entire measurement—comprising 15 points–in under 30 min. Despite the fact that NAA is considered a neuronal viability marker whose concentration has been shown to vary considerably post stroke23, data from N=6 rats revealed that NAA T1s remains unchanged by the onset of ischaemia , in agreement with a previous lower field study19. By contrast, the Lac signal shows a ~50% increase from a contralateral value to in the ipsilateral hemisphere at the very early time point of 3-h post ischaemia (P<0.05). This increase in apparent T1 suggests that lactate weakens its average interactions with the macromolecular structures in the host tissue. Cre and Cho , on the other hand, exhibit only minor T1 changes 3-h post ischaemia, remaining statistically unchanged in both hemispheres upon stroke. Figure 5d–f illustrates analogous experiments for a representative rat, but focusing on metabolic T2s at 24-h post ischaemia. These relaxation data show (a) long T2s in the range of 100–170 ms for all metabolites, values that could be somewhat biased towards longer T2 species owing to the long TEs explored, and (b) consistently slower decays in the ipsilateral hemisphere, indicating again weaker interactions between metabolites and macromolecules within host tissues upon stroke. Notably, the relatively long T2s and short T1s of metabolites compared with water at 21.1 T support the benefits of the RE high-field MRS sequence, and open new possibilities for the application of more advanced spectroscopic techniques, such as multi-dimensional spectral and high-definition spatial/spectral acquisitions.
Probing metabolic interactions within tissues non-invasively and in vivo is a long-standing challenge, particularly when elucidating the intricate relationships between metabolism, structure and function in health and disease14,15. Contrary to positron emission tomography (PET) or hyperpolarized 13C MRS, which require injections of radiolabelled tracers or large influxes of slowly relaxing stable isotopes, 1H MRS utilizes endogenous brain metabolites at physiological concentrations and conditions as molecular reporters. Despite this ideal scenario, MRS is generally limited by the low sensitivity associated with metabolic concentrations. This study sensitizes these measurements by focusing observations to only a few metabolites whose spectral positions are a priori defined and executing selective excitation echo experiments at ultrahigh magnetic fields. A sensitivity synergy then emerges combining the high SNR provided by a state-of-the-art magnet, an optimized radiofrequency coil design, the enhanced field-dependent spectral dispersion that allows one to target the desired metabolites in a very selective manner, cross-relaxation and exchange-induced repolarization effects that arise when leaving the bulk pool of solvent and macromolecular 1Hs untouched, and an echo sequence whereby any residual water that might have been excited decays before the data acquisition. Particularly valuable to stress are the favourable relaxation properties that arise for performing non-water-suppressed MRS at 21.1 T, with relatively short metabolic T1s and long metabolic T2s compared with their water 1H counterparts, facilitating the acquisition of flat baseline spectra. Even if TEs are inherently long, these synergies then result in a very high SNR per unit time and in clean, undistorted baselines; robust spectral features that in turn open avenues of research that have so far eluded MRS. As demonstrated, one such opportunity relied on using diffusion-based dPFG to probe complex metabolic confinements in normal and diseased CNS. When applied to monitor the behaviour of four metabolites, these MR signals unequivocally demonstrated hallmark (yet previously unobserved) signatures for restricted diffusion in randomly oriented, anisotropic structures. Apart from this basic insight, the angular dPFG experiments revealed that Lac diffuses in a different environment than the remaining metabolites. This could help elucidate the nature of conventional diffusion experiments reporting that upon ischaemia water exhibits a decreased diffusivity; in the metabolite-based measurements, this decrease appears to be correlated to increases in the apparent eccentricity of the underlying microstructures. The intriguing stroke- and metabolite-dependent eccentricities revealed by the dPFG experiments warrant further studies to elucidate at a microscopic level the interactions between ischaemic tissues and metabolites, their evolution with recovery and therapies vis-à-vis specific neural tissue elements, as well as their interpretation within the frame of more complex diffusion analytical models 45. Another objective of this study centred on the spectral resonances appearing downfield from water, which have been notoriously challenging to characterize at lower fields owing to difficulties in avoiding water-suppression schemes. These drawbacks disappear with the application of a sculpted downfield excitation, thereby leading to intense signals that could be measured in under 10 min to provide information that clearly discriminated healthy tissue from diseased. As these downfield resonances represent different metabolites from those conventionally observed containing, for instance, the signatures of ATP and NAD42,46, such characterizations are expected to provide insights into stroke-related bioenergetics and redox changes. RE MRS also lends itself to efficiently probe metabolic relaxation rates, another set of potential biomarkers for disease and compartmentalization. In this respect it is worth noting that whereas previous studies had reported changes in NAA, Cre and Cho T1s beginning around 24-h post ischaemia and associated them to the onset of vasogenic oedema19, the sensitivity endowed by RE MRS allowed us to measure increases in Lac’s T1 as early as 3-h post ischaemia, coinciding with the onset of cytotoxic oedema. In principle, this kind of advantages should also materialize in other tissues as well as for different pathologies. From a physical standpoint, nothing fundamental would prevent these synergies to act as well in ultrahigh-field human brain studies— even if performing such extension would require dealing with the relatively high specific absorption rate exhibited by the localization modules used in the present study.
It is worth concluding by reflecting on other new avenues that become accessible by the high SNR offered by RE MRS. These include further relaxation measurements based on Overhauser effects that could aid in peak assignment and in further probing small/macromolecular interactions, saturation-exchange variants that measure solvent accessibility of different sites, multi-dimensional acquisitions based on J couplings to further resolve and assign ambiguous resonances, and additional diffusion-based metabolic measurements. All of these methods require high sensitivity, but are judged compatible with in vivo scanning time scales given the SNR demonstrated in Figs 2, 3, 4, 5. Another worthy extension includes the realization of accelerated spectroscopic imaging experiments: the fact that the chemical shifts of the targeted metabolites are known a priori implies that selective excitation could be combined with accelerated imaging approaches in order to measure metabolic location with good sensitivity and unprecedented spatial resolutions in reasonable acquisition times. Alternatively, this advancement could open new possibilities for performing in vivo functional MRS and MRSI studies with adequate temporal resolutions. These vistas, as well as further characterizations of health, disease and cellular metabolism based on the present MRS approach, are currently under investigation.
All experiments in this study were pre-approved by the Florida State University (FSU) Animal Care and Use Committee (protocol no. 1038), which has been accredited by the Association for Assessment and Accreditation of Laboratory Animal Care, International (AAALAC). FSU is registered as a research facility with the United States Department of Agriculture (registration no. 58-R-0001) and has an Animal Welfare Assurance (no. A3854-01) on file with the US Public Health Service. All animal procedures were performed according to these regulatory bodies and AAALAC guidelines, and every effort was taken to minimize animal suffering, as directed and overseen by a veterinarian who is certified as a specialist in laboratory animal medicine by the American College of Laboratory Animal Medicine.
The animals used in this study were juvenile male Sprague–Dawley rats weighing 250 g and age 1.5–2 months at the time of the experiment. The animals were housed in 12 h light/dark cycles.
Surgical procedures were performed under aseptic conditions. Ischaemia-reperfusion was achieved by occluding the MCA of juvenile Sprague–Dawley rats for 1.5 h. The animals were anaesthetized with 5% isoflurane and maintained with ~2% isoflurane using a nose cone. A rubber-coated filament (Doccol Corp., Sharon, MA) was guided 1.9 cm through the external carotid artery until the MCA was blocked and blood flow was interrupted to the brain region served by the MCA. Transient occlusion occurred for 1.5 h followed by re-anaesthetization induced again by 5% isoflurane and maintained by 2% isoflurane. The filament was carefully removed to allow reperfusion. Animals were treated to minimize any discomfort and then placed back in their cage for recovery. The same rats were used throughout the experimental time points in this study, including experiments performed both 3- and 24-h post ischaemia.
All experiments in this study were performed with the vertical 21.1-T MRI scanner (11-cm bore size, 6.35-cm gradient bore size) located in the National High Magnetic Field Laboratory Users Facility, operating at a 1H frequency of 900 MHz and equipped with a Bruker Avance III console (Bruker-Biospin, Billerica, MA). The gradient system used is capable of producing magnetic field gradients of up to 600 mT m−1 in all directions, with a rise time of 120 μs. For both excitation and detection, a home-built quadrature half-saddle coil was used possessing a 33-mm inner diameter, a loaded Q =131 (130 and 132 for each channel), and delivering a ~125-μs hard pulse using ~80 W of peak power). Before experiments, anaesthesia was induced with 5% isoflurane, followed by ~2% for maintenance delivered through a nose cone throughout the MRI scans. The animals were kept at a constant temperature in the MRI scanner by means of gradient chiller temperature and their breathing rate was monitored (SA Instruments, Stonybrook, NY) throughout the experiments and kept at 30–50 breaths per minute. All experiments were respiratory gated.
Preparation, refocusing, localization pulses and MRS processing
All pulses herein used were derived from the Shinar LeRoux algorithm47. For upfield metabolites, an 8-ms polychromatic multiband excitation pulse was designed, targeting only the resonances of interest (Lac, Cre, Cho and NAA). The downfield metabolites shown in Fig. 4 were excited by a single-band 8-ms pulse whose right-most stop band reached ~5.5 p.p.m. Single-band, frequency-swept, quadratic phase refocusing pulses of 4 ms durations, 1.3 kHz B1max and 4.5 p.p.m. bandwidth were used to refocus chemical shift evolutions accrued during the preparation pulses. The localization was achieved using the 3D-LASER (localization by adiabatic selective refocusing) methodology48 that entailed the applications of three pairs of adiabatic 5-ms 1.6 kHz B1max and 20 p.p.m. bandwidth slice-selective refocusing pulses imparting spatial selectivity in all three dimensions, respectively. Under these localization conditions, the maximum shift-driven displacement between the voxels associated to the different metabolites was under 1 mm. Two voxels of interest spanning a 5 × 5 × 5 (mm)3 volume were then located: one at the core of the ischaemic region and another symmetrically placed in the contralateral hemisphere. The quality of the MRS localization was ascertained by collecting images incorporating identical LASER localization modules. Spectra were processed by subjecting the conventionally averaged time domain signals to zero filling (32 k), apodization with a 25-Hz exponential line broadening, Fourier transform and magnitude calculation.
dPFG MRS experiments
These restricted diffusion correlation experiments36,37,38,45 relied on two gradient pairs G1 and G2, of duration δ and separation Δ (Fig. 1, shaded filter) separated by a long mixing time (tm). The magnitude and direction of G1 was kept constant, while the relative orientation of the second gradient G2 varied about the axis subtended by G1, that is, the relative angle ψ between the two gradients is the variant in angular dPFG. Localized dPFG MRS experiments were performed in the rat brains 24-h post ischaemia with |G1|=|G2|=48 G cm−1, Δ=53.5 ms, δ=2.5 ms and tm=24 ms on a voxel size of 5 × 5 × 5 (mm)3 placed within the stroke or in the contralateral hemisphere. Each trace was acquired with TR/TE =1,500/187 ms and number of averages (NA)=160, resulting in 4 min of scan time per trace or 36 min for the nine ψ values spanning 0:45:360 degrees. The amplitude modulation for the peaks was quantified by fitting the data to a simple S(ψ)/S0= A+B(cos(2ψ)) curve in MATLAB (Mathworks, Nattick, MA), and the amplitude modulation (B) was then used to extract the L/R ratios for each metabolite in the stroked region and contralateral hemisphere.
Apparent metabolic T1 measurements
Apparent T1s were measured in both ipsi- and contralateral hemispheres of rats 3 h post ischaemia by applying a progressive saturation filter that entailed 16 dummy scans and 48 signal averages for TRs ranging between 0.7 and 7.1 s. These TRs were randomized to avoid any potential consistent effects. The data were then fit to the classic T1 exponential buildup curves: M(TR) = M0[1−exp(−TR/T1)]+y0.
Apparent metabolic T2 measurements
Apparent T2s were measured in both ipsi- and contralateral hemispheres of rats 24 h post ischaemia by increasing the effective TE of the measurements, that is, by varying in an equidistant fashion the refocusing pulse separation (denoted under ‘Mechanism’ in Fig. 1) using a long TR of 6.5 s. Eight dummy scans and 16 signal averages were used for TEs ranging between 54 and 250 ms. TEs were randomized to avoid any potential systematic errors. The data was then fit to a classic T2 exponential decay: M(TE) = M0[exp(−TE/T2)].
How to cite this article: Shemesh, N. et al. Metabolic properties in stroked rats revealed by relaxation-enhanced magnetic resonance spectroscopy at ultrahigh fields. Nat. Commun. 5:4958 doi: 10.1038/ncomms5958 (2014).
Craddock, R. C. et al. Imaging human connectomes at the macroscale. Nat. Methods 10, 524–539 (2013).
Toga, A. W. et al. Towards multimodal atlases of the human brain. Nat. Rev. Neurosci. 7, 952–966 (2006).
Benzinger, T. L. S. et al. Regional variability of imaging biomarkers in autosomal dominant Alzheimer's disease. Proc. Natl Acad. Sci. USA 110, E4502–E4509 (2013).
Emblem, K. E. et al. Vessel architectural imaging identifies cancer patient responders to anti-angiogenic therapy. Nat. Med. 19, 1178–1183 (2013).
Zhou, J. Y. et al. Using the amide proton signals of intracellular proteins and peptides to detect pH effects in MRI. Nat. Med. 9, 1085–1090 (2003).
Wedeen, V. J. et al. The geometric structure of the brain fiber pathways. Science 335, 1628–1634 (2012).
Le Bihan, D. Looking into the functional architecture of the brain with diffusion MRI. Nat. Rev. Neurosci. 4, 469–480 (2003).
Li, P. & Murphy, T. H. Two-photon imaging during prolonged middle cerebral artery occlusion in mice reveals recovery of dendritic structure after reperfusion. J. Neurosci. 28, 11970–11979 (2008).
Budde, M. D. & Frank, J. A. Neurite beading is sufficient to decrease the apparent diffusion coefficient after ischemic stroke. Proc. Natl Acad. Sci. USA 107, 14472–14477 (2010).
Myers, M. G. & Olson, D. P. Central nervous system control of metabolism. Nature 491, 357–363 (2012).
Somel, M., Liu, X. L. & Khaitovich, P. Human brain evolution: transcripts, metabolites and their regulators. Nat. Rev. Neurosci. 14, 112–127 (2013).
Manji, H. et al. Impaired mitochondrial function in psychiatric disorders. Nat. Rev. Neurosci. 13, 293–307 (2012).
Choi, C. et al. 2-hydroxyglutarate detection by magnetic resonance spectroscopy in IDH-mutated patients with gliomas. Nat. Med. 18, 624–629 (2012).
de Graaf, R. A. In-Vivo NMR Spectroscopy: Principles and Techniques 2nd edn John Wiley and Sons Ltd (2007).
Duarte, J. M. N., Lei, H. X., Mlynarik, V. & Gruetter, R. The neurochemical profile quantified by in vivo H-1 NMR spectroscopy. Neuroimage 61, 342–362 (2012).
Marjanska, M. et al. Monitoring disease progression in transgenic mouse models of Alzheimer's disease with proton magnetic resonance spectroscopy. Proc. Natl Acad. Sci. USA 102, 11906–11910 (2005).
Soares, D. P. & Law, M. Magnetic resonance spectroscopy of the brain: review of metabolites and clinical applications. Clin. Radiol. 64, 12–21 (2009).
Dijkhuizen, R. M., de Graaf, R. A., Tulleken, K. A. F. & Nicolay, K. Changes in the diffusion of water and intracellular metabolites after excitotoxic injury and global ischemia in neonatal rat brain. J. Cereb. Blood Flow Metab. 19, 341–349 (1999).
vanderToorn, A., Dijkhuizen, R. M., Tulleken, C. A. F. & Nicolay, K. T-1 and T-2 relaxation times of the major H-1-containing metabolites in rat brain after focal ischemia. NMR Biomed. 8, 245–252 (1995).
Nicolay, K. et al. Diffusion NMR spectroscopy. NMR Biomed. 14, 94–111 (2001).
Cudalbu, C., Mlynarik, V., Xin, L. J. & Gruetter, R. Comparison of T-1 relaxation times of the neurochemical profile in rat brain at 9.4 Tesla and 14.1 Tesla. Magn. Reson. Med. 62, 862–867 (2009).
de Graaf, R. A. et al. High magnetic field water and metabolite proton T-1 and T-2 relaxation in rat brain in vivo. Magn. Reson. Med. 56, 386–394 (2006).
Demougeot, C. et al. N-acetylaspartate, a marker of both cellular dysfunction and neuronal loss: its relevance to studies of acute brain injury. J. Neurochem. 77, 408–415 (2001).
Dreher, W., Busch, E. & Leibfritz, D. Changes in apparent diffusion coefficients of metabolites in rat brain after middle cerebral artery occlusion measured by proton magnetic resonance spectroscopy. Magn. Reson. Med. 45, 383–389 (2001).
Shemesh, N., Dumez, J. N. & Frydman, L. Longitudinal relaxation enhancement in H-1 NMR spectroscopy of tissue metabolites via spectrally selective excitation. Chem. Euro. J. 19, 13002–13008 (2013).
Schanda, P. Fast-pulsing longitudinal relaxation optimized techniques: enriching the toolbox of fast biomolecular NMR spectroscopy. Prog. Nucl. Magn. Reson. Spectrosc. 55, 238–265 (2009).
Moseley, M. E. et al. Early detection of regional cerebral-ischemia using high-speed MRI. Stroke 24, I60–I65 (1993).
Schlaug, G. et al. Time course of the apparent diffusion coefficient (ADC) abnormality in human stroke. Neurology 49, 113–119 (1997).
Beaulieu, C. The basis of anisotropic water diffusion in the nervous system - a technical review. NMR Biomed. 15, 435–455 (2002).
Moffett, J. R. et al. N-acetylaspartate in the CNS: From neurodiagnostics to neurobiology. Prog. Neurobiol. 81, 89–131 (2007).
Harada, M. et al. Diffusion-weighted in vivo localized proton MR spectroscopy of human cerebral ischemia and tumor. NMR Biomed. 15, 69–74 (2002).
Marchadour, C. et al. Anomalous diffusion of brain metabolites evidenced by diffusion-weighted magnetic resonance spectroscopy in vivo. J. Cereb. Blood Flow Metab. 32, 2153–2160 (2012).
Valette, J. et al. A new sequence for single-shot diffusion-weighted NMR spectroscopy by the trace of the diffusion tensor. Magn. Reson. Med. 68, 1705–1712 (2012).
Kan, H. E. et al. Differences in apparent diffusion coefficients of brain metabolites between grey and white matter in the human brain measured at 7 T. Magn. Reson. Med. 67, 1203–1209 (2012).
Wood, E. T. et al. Investigating axonal damage in multiple sclerosis by diffusion tensor spectroscopy. J. Neurosci. 32, 6665–6669 (2012).
Mitra, P. P. Multiple wave-vector extensions of the NMR pulsed-field-gradient spin-echo diffusion measurement. Phys. Rev. B 51, 15074–15078 (1995).
Özarslan, E. Compartment shape anisotropy (CSA) revealed by double pulsed field gradient MR. J. Magn. Reson. 199, 56–67 (2009).
Shemesh, N., Adiri, T. & Cohen, Y. Probing microscopic architecture of opaque heterogeneous systems using double-pulsed-field-gradient NMR. J. Am. Chem. Soc. 133, 6028–6035 (2011).
MacMillan, E. L. et al. Magnetization exchange with water and T-1 relaxation of the downfield resonances in human brain spectra at 3.0 T. Magn. Reson. Med. 65, 1239–1246 (2011).
MacMillan, E. L., Boesch, C. & Kreis, R. Magnetization exchange observed in human skeletal muscle by non-water-suppressed proton magnetic resonance spectroscopy. Magn Reson. Med. 70, 916–924 (2012).
van Zijl, P. C. & Moonen, C. T. In situ changes in purine nucleotide and N-acetyl concentrations upon inducing global ischemia in cat brain. Magn. Reson. Med. 29, 381–385 (1993).
Govindaraju, V., Young, K. & Maudsley, A. A. Proton NMR chemical shifts and coupling constants for brain metabolites. NMR Biomed. 13, 129–153 (2000).
Adams, B. & Lerner, L. E. Effect of stereochemistry on hydroxyl proton chemical-shifts and coupling-constants in carbohydrates. Magn. Reson. Chem. 32, 225–230 (1994).
Lei, H., Zhang, Y., Zhu, X. H. & Chen, W. Changes in the proton T-2 relaxation times of cerebral water and metabolites during forebrain ischemia in rat at 9.4 T. Magn. Reson. Med. 49, 979–984 (2003).
Finsterbusch, J Multiple Wave Vector Diffusion Weighted NMR. Ann. Reports NMR Spectrosc 72, 225–299 (2011).
Graaf, R. A. & Behar, K. L. "Detection of cerebral NAD+ by in vivo1H NMR spectroscopy”. NMR Biomed. 27, 802–809 (2014).
Pauly, J., Leroux, P., Nishimura, D. & Macovski, A. Parameter relations for the Shinnar-Leroux selective excitation pulse design algorithm. IEEE Trans. Med. Imaging 10, 53–65 (1991).
Garwood, M. & DelaBarre, L. The return of the frequency sweep: designing adiabatic pulses for contemporary NMR. J. Magn. Reson. 153, 155–177 (2001).
We thank Ashley Blue and Fabian Calixto-Bejarano for their technical assistance. Funding for this study was provided by the US National Science Foundation and National High Magnetic Field Laboratory (NHMFL, DMR-0654118), the User Collaboration Group Program (to S.C.G.) as well as by the Israel Science Foundation (grant ISF 1142/13), a Helen and Martin Kimmel Award for Innovative Investigation and the generosity of the Perlman Family Foundation (to L.F.). N.S. acknowledges a Dean’s Fellowship (WIS) and a Visiting Scientist Program grant (NHMFL, programme #12601). J.-N.D. acknowledges the EC for a Marie Curie Action ITN METAFLUX (project 264780) fellowship. S.C.G. acknowledges the American Heart Association Grant-in-Aid Program (10GRNT3860040).
The authors declare no competing financial interests.
About this article
Cite this article
Shemesh, N., Rosenberg, J., Dumez, JN. et al. Metabolic properties in stroked rats revealed by relaxation-enhanced magnetic resonance spectroscopy at ultrahigh fields. Nat Commun 5, 4958 (2014). https://doi.org/10.1038/ncomms5958
This article is cited by
Translational Stroke Research (2022)
Scientific Reports (2018)
Brain Structure and Function (2018)
Scientific Reports (2016)